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ARIC Study
Abdirahim Rashid, MD; Anandita Agarwala, MD; Eric Novak, MS; David L. Brown, MD
Background-—Traditional risk factors for heart failure––coronary heart disease, hypertension, diabetes mellitus, obesity, and
smoking––only account for about 50% of cases. Thus, the identiﬁcation of novel risk factors is of signiﬁcant public health
importance. As high birth weight infants are at increased risk for obesity and diabetes mellitus later in life, which are both risk
factors for the development of heart failure, we sought to assess the association of high birth weight with incident heart failure in
the ARIC (Atherosclerosis Risk in Communities) study.
Methods and Results-—The ARIC study is a biracial prospective community-based investigation of 15 792 individuals aged 45 to
64 years at baseline. Study participants who were born premature or born a twin were excluded from this analysis, resulting in
9820 participants who provided either their birth weight category (low, medium, high) or exact birth weight. After adjusting for
differences in demographics, risk factors, and comorbidities, compared with medium birth weight, those with high birth weight had
a signiﬁcantly increased risk of incident heart failure (hazard ratio, 1.27; 95% CI, 1.05–1.54 [P=0.014]). The hazard for all-cause
mortality for high birth weight compared with medium birth weight was 1.16 (95% CI, 0.99–1.34; P=0.06). There was no
association of high birth weight with myocardial infarction (hazard ratio, 1.06; 95% CI, 0.84–1.34 [P=0.6]).
Conclusions-—High birth weight was associated with a signiﬁcantly increased hazard of incident heart failure independent of
traditional risk factors and a trend toward an increased hazard of death. A history of high birth weight should be ascertained in
young adults for primordial prevention of heart failure and in older adults for primary prevention. ( J Am Heart Assoc. 2019;8:
e011524. DOI: 10.1161/JAHA.118.011524.)
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H eart failure (HF) is a global pandemic affecting morethan 26 million patients worldwide1 that is best
addressed by intervening on risk factors for HF before the
HF phenotype develops. The traditional risk factors for HF––
hypertension, coronary heart disease (CHD), diabetes mel-
litus, smoking, and obesity––account for only about half of
the population-attributable risk.2 Thus, identiﬁcation of novel
risk factors for HF is of signiﬁcant public health importance.
One potential nontraditional risk factor is birth weight. The
fetal origins of adult diseases hypothesis postulates that
maladaptive changes in utero as a response to environmen-
tal stressors lead to permanent changes that persist
throughout life predisposing to the development of chronic
diseases.3
Low birth weight (LBW) (<2.5 kg) has been considered a
surrogate marker of fetal malnutrition.3 Most studies on
outcomes related to birth weight have focused on LBW with
several studies linking LBW to the development of CHD4,5 and
hypertension.6–8 High birth weight (HBW) (>4 kg) is com-
monly associated with maternal obesity, gestational diabetes
mellitus, and greater maternal weight gain during pregnancy.9
HBW infants are at increased risk of developing obesity10,11
and type 2 diabetes mellitus12 later in life, both of which are
risk factors for HF.2 We hypothesized that HBW would be
associated with an increased risk of incident HF in a large
biracial sample of community-dwelling adults enrolled in the
ARIC (Atherosclerosis Risk in Communities) study.
Participants and Methods
Data Source
The ARIC data set was obtained upon request from the
Biologic Specimen and Data Repository Information Coordi-
nating Center (BioLINCC) of the National Heart, Lung, and
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Blood Institute under a data use agreement. The Washington
University Human Research Protection Ofﬁce granted this
study an exemption from institutional review board oversight.
Because of the sensitive nature of the data collected for this
study, requests to access the data set from qualiﬁed
researchers trained in human subject conﬁdentiality protocols
may be sent to BioLINCC (https://biolincc.nhlbi.nih.gov).
Study Participants
The ARIC study is a prospective cohort trial investigating the
etiology of atherosclerotic disease in biracial community-
dwelling men and women between the ages of 45 and 64
years who were selected by probability sampling from 4
communities in the United States (Minneapolis, MN; Wash-
ington County, MD; Forsyth County, NC; Jackson, MS).13 The
institutional review boards at all participating centers
approved the ARIC study protocol and all participants
provided informed consent.
From 1987–1989, 15 792 participants attended the
baseline clinical examination (visit 1). Subsequent visits were
at 3-year intervals (visit 2 in 1990–1992; visit 3 in 1993–
1995; visit 4 in 1996–1998) except for visit 5 (2011–2013).
Participants have been contacted annually (semiannually
beginning in 2012) to obtain information about hospitaliza-
tions and for additional data collection. At visit 4, 11 656
participants were asked their birth weight in pounds and
ounces. Recalled exact birth weight was converted to
kilograms. Those who could not provide their exact birth
weight were asked to categorize their birth weight as low,
medium, or high. LBW was deﬁned as <2.5 kg, medium birth
weight (MBW) as 2.5 to 4 kg, and HBW as ≥4 kg. Study
participants who were born a twin or premature were
excluded. This resulted in a total of 9820 participants who
provided either their exact birth weight or birth weight
category (complete cohort) included in this analysis, of whom
4776 provided their exact birth weight (exact birth weight
subgroup). Additional information was obtained from the
baseline examination during visit 1 including anthropometric
data, medical history, and cholesterol measurements.
Outcomes
The primary outcome of interest was incident HF, deﬁned as
the ﬁrst occurrence of a hospitalization with an HF diagnosis
according to International Statistical Classiﬁcation of Diseases
codes in any position or a death certiﬁcate with death from HF
in any position.14 Secondary outcomes included all-cause
mortality and myocardial infarction (MI). Follow-up time for
outcome events was deﬁned as the time from their baseline
examination until the incident event.
Deaths were determined by annual (or later, semiannual)
telephone calls, linkage to local hospital and state health
department records, or, for those lost to follow-up, linkage to
the National Death Index. MI was deﬁned by ≥1 of the
following: evolving diagnostic ECG changes, diagnostic ECG
pattern and abnormal cardiac enzymes/biomarkers, or
cardiac pain and abnormal enzymes/biomarkers and evolving
ST-T pattern or equivocal ECG pattern.13 Abstracted hospi-
talization events were classiﬁed by the ARIC Mortality and
Morbidity Classiﬁcation Committee.
The following methods were used for ascertainment of
events in addition to the scheduled examinations: (1) patients
were interviewed annually by phone about interim hospital-
izations; (2) local hospitals provided lists of hospital dis-
charges with cardiovascular diagnoses and were reviewed to
identify ARIC cohort hospitalizations; and (3) health depart-
ment death certiﬁcate ﬁles were continuously surveyed.15
Covariates
The amount of ethanol use, level of education, and presence
of left ventricular hypertrophy (LVH) as deﬁned by the sex-
speciﬁc Cornell voltage criteria on a 12-lead ECG were
obtained during visit 1. Hypertension was deﬁned as systolic
blood pressure (BP) ≥140 mm Hg and diastolic BP
≥90 mm Hg or the use of antihypertensive medications.
Diabetes mellitus was deﬁned as a fasting plasma glucose
level ≥126 mg/dL, a nonfasting plasma glucose level
≥200 mg/dL, or a self- reported history of diabetes mellitus
diagnosed by a physician or treatment for diabetes mellitus.
Information on prevalent CHD was obtained in visit 1 and
deﬁned as presence of MI from the adjudicated visit 1 ECG, by
a history of MI, or revascularization such as coronary artery
bypass surgery or percutaneous coronary intervention.
Statistical Analysis
Continuous variables were summarized as meanSD. Cate-
gorical variables were summarized by frequency count
Clinical Perspective
What Is New?
• This study demonstrates an association between high
weight at birth and subsequent development of heart failure
as an adult.
What Are the Clinical Implications?
• A history of high birth weight should be ascertained in young
adults for primordial prevention of heart failure and in older
adults for primary prevention.
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(percentage). Comparisons between birth weight groups were
conducted using 2-sample Student t test and Fisher exact test
for continuous and categorical variables, respectively. Vari-
ables with a non-normal distribution were summarized by the
median (ﬁrst quartile, third quartile) and compared with the
Mann–Whitney U test. When comparing >2 groups, ANOVA,
Fisher exact test, and Kruskal–Wallis test were used when
evaluating continuous, categorical, and non-normal/ordinal
data, respectively.
Crude outcome event rates were calculated and com-
pared between birth weight groups using Fisher exact test.
Kaplan–Meier curves were created for each group and
compared with the log-rank test. Unadjusted and adjusted
Cox proportional hazards models were created for mortality,
MI, and incident HF. Variables with P<0.10 in univariate
birth weight group comparisons were included in the model
as were variables selected based on clinical knowledge. The
ﬁnal model then included age, sex, body mass index (BMI),
current and former smoking, ethanol intake, hypertension,
diabetes mellitus, LVH, income, systolic BP, and high-
density lipoprotein cholesterol. All analyses were conducted
in SAS version 9.4 (SAS Institute Inc).
Table 1. Baseline Characteristics by Birth Weight Category in Complete Cohort
Variable Overall (N=9820) LBW (n=331) MBW (n=8771) HBW (n=718) P Value
Age, y 53.95.7 53.85.7 53.85.7 54.15.6 0.38
Female 5477 (56) 261 (79) 4941 (56) 275 (38) <0.001
Race <0.001
Black 1920 (20) 91 (27) 1723 (20) 106 (15)
White 7900 (80) 240 (73) 7048 (80) 612 (85) <0.001
BMI, kg/m2 <0.001
BMI <25 3325 (34) 131 (40) 2996 (34) 198 (28)
BMI 25 to 29.9 3930 (40) 104 (32) 3527 (40) 299 (42)
BMI ≥30 2259 (26) 95 (29) 2244 (26) 220 (31)
Smoking status <0.001
Current 2098 (21) 76 (23) 1833 (21) 189 (26)
Former 3308 (34) 82 (25) 2939 (34) 287 (40)
Never 4407 (45) 172 (52) 3395 (46) 240 (34)
Ethanol intake, g/wk 41.788.7 23.864.5 41.488.0 53.4103.4 <0.001
Hypertension 2988 (31) 124 (38) 2660 (30) 204 (29) 0.009
CHD 360 (4) 6 (2) 324 (4) 30 (4) 0.16
Diabetes mellitus 679 (7) 29 (9) 597 (7) 53 (7) 0.32
LVH 143 (2) 7 (2) 126 (1) 10 (1) 0.54
Total cholesterol, mg/dL 21541 21844 21541 21339 0.16
HDL cholesterol, mg/dL 51.817 54.917 52.217 49.115 <0.001
Birth weight, kg* 3.500.71 2.150.32 3.360.41 4.800.56 <0.001
Income <0.001
$0 to $15 999 1549 (17) 88 (28) 1385 (17) 76 (11)
$16 000 to $34 999 3097 (33) 104 (34) 2767 (33) 226 (33)
$35 000+ 4675 (50) 118 (38) 4176 (50) 381 (56)
SBP, mm Hg 11917 12318 11917 11918 0.002
DBP, mm Hg 7311 7310 7311 7210 0.30
GFR MDRD, mL/min per 1.73 m2 6711 6812 6811 6811 0.24
Values are expressed as number (percentage) or meanSD. BMI indicates body mass index; CHD, coronary heart disease; DBP, diastolic blood pressure; GFR MDRD, glomerular ﬁltration
rate as calculated in the Modiﬁcation of Diet in Renal Disease study; HBW, high birth weight; HDL, high-density lipoprotein; LBW, low birth weight; LVH, left ventricular hypertrophy; MBW,
medium birth weight; SBP, systolic blood pressure.
*Includes only the 4776 participants who provided exact birth weight.
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Results
Of 9820 participants, 331 (3%) were born LBW, 8771 (89%)
NBW, and 718 (7%) HBW (Table 1). Patients were predomi-
nately white (80%) and female (56%), and mean age was
53.95.7 years at the time of enrollment. Median follow-up
was 22.8 years (25th, 75th percentiles 20.9, 23.7 years).
LBW individuals were more often female, had a BMI <25, and
reported lower income. HBW infants were more often male,
overweight or obese at ARIC study entry, current or former
smokers, with higher ethanol intake and lower high-density
lipoprotein cholesterol levels (Table 1). There were no
signiﬁcant differences in hypertension, diabetes mellitus,
LVH, and CHD between birth weight categories at the time of
study enrollment. A separate analysis of the 4776 study
participants who were able to provide their exact birth weight
revealed that 215 (4.5%) were LBW, 3946 (82%) were MBW,
and 616 (13%) were HBW (Table 2). LBW among these
individuals was also more common in women, those with an
adult BMI <25, and those of lower income. HBW individuals
were more often current or former smokers and greater
consumers of alcohol, with lower high-density lipoprotein
cholesterol levels. Likewise, among participants with known
birth weight, hypertension, diabetes mellitus, LVH, and CHD
Table 2. Baseline Characteristics by Birth Weight Category in Exact Birth Weight Subgroup
Variable Overall (N=4776) LBW (n=215) MBW (n=3946) HBW (n=616) P Value
Age, y 53.35.7 53.15.4 53.25.7 54.25.6 <0.001
Female 2827 (59) 185 (86) 2396 (61) 246 (40) <0.001
Race 0.27
Black 686 (14) 34 (16) 576 (15) 76 (12)
White 4090 (86) 181 (84) 3370 (85) 539 (88)
BMI (kg/m2) 0.007
BMI <25 1669 (35) 87 (40) 1398 (35) 184 (30)
BMI 25 to 29.9 1845 (39) 66 (31) 1529 (39) 250 (41)
BMI ≥30 1261 (26) 62 (29) 1019 (26) 180 (29)
Smoking status <0.001
Current 1039 (22) 42 (20) 829 (21) 168 (27)
Former 1634 (34) 58 (27) 1331 (34) 245 (40)
Never 2098 (44) 114 (53) 1784 (45) 200 (33)
Ethanol intake 43.489.5 23.158.8 43.088.4 53.4103.1 <0.001
Hypertension 1325 (28) 70 (33) 1083 (28) 172 (28) 0.25
CHD 149 (3) 3 (1) 121 (3) 25 (4) 0.15
Diabetes mellitus 332 (7) 21 (10) 265 (7) 46 (8) 0.20
LVH 60 (1) 3 (1) 47 (1) 10 (2) 0.51
Total cholesterol, mg/dL 21341 21746 21340 21340 0.33
HDL cholesterol, mg/dL 52.617 56.819 53.017 48.715 <0.001
Birth weight, kg 3.500.71 2.150.32 3.360.41 4.800.56 <0.001
Income 0.003
$0 to $15 999 642 (14) 42 (21) 538 (14) 62 (11)
$16 000 to $34 999 1412 (31) 68 (33) 1155 (31) 189 (32)
$35 000+ 2499 (55) 93 (46) 2074 (55) 332 (57)
SBP, mm Hg 11817 12117 11817 11918 0.11
DBP, mm Hg 7210 7210 7310 7210 0.53
GFR MDRD, mL/min per 1.73 m2 67.511 66.511.6 67.411 68.410.9 0.039
Values are expressed as number (percentage) or meanSD. BMI indicates body mass index; CHD, coronary heart disease; DBP, diastolic blood pressure; GFR MDRD, glomerular ﬁltration
rate as calculated in the Modiﬁcation of Diet in Renal Disease study; HBW, high birth weight; HDL, high-density lipoprotein; LBW, low birth weight; LVH, left ventricular hypertrophy; MBW,
medium birth weight; SBP, systolic blood pressure.
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did not differ between birth weight groups at the time of
enrollment.
The unadjusted crude outcome rates are displayed in
Table 3. Among the complete cohort, there were 2411 (25%)
deaths, 1000 (10%) MIs, and 1380 (15%) incident HF events,
whereas among those with exact birth weight there were
1087 (23%) deaths, 467 (10%) MIs, and 637 (14%) incident HF
events. In both the complete cohort and the exact birth
weight subgroup, death and incident HF were signiﬁcantly
related to birth weight category, with numerically more deaths
and incident HF in HBW individuals.
Figure 1A through 1C depict the survival curves for
incident HF, MI, and all-cause mortality among the complete
cohort. There was lower incident HF-free survival and overall
survival in individuals with HBW. Analysis limited to the study
participants who provided an exact birth weight (Figure 2A
through 2C) did not alter the association of HBW with
impaired overall survival and incident HF-free survival. Survival
free of MI did not differ signiﬁcantly between birth weight
categories in the complete cohort or the subgroup with exact
birth weights.
On Cox proportional hazards analysis of the complete
cohort, HBW compared with MBW was positively associated
with a signiﬁcantly increased hazard of incident HF (hazard
ratio [HR], 1.27; 95% CI, 1.05–1.54 [P=0.014]) (Table 4).
Other variables independently associated with incident HF
included age, female sex, overweight or obesity, current or
former smoking, higher ethanol intake, hypertension, diabetes
mellitus, LVH, greater income, systolic BP, and high-density
lipoprotein cholesterol. LBW was not associated with incident
HF. HBW was also associated with a trend toward an increase
in mortality (HR, 1.16; 95% CI, 0.99–1.34 [P=0.06]) but not
with an increased hazard of incident MI (HR, 1.06; 955 CI,
0.84–1.34 [P=0.60]). In the individuals who provided exact
Table 3. Outcomes in the Complete Cohort and Exact Birth
Weight Subgroup












Death 2411 (25) 76 (23) 2119 (24) 216 (30) 0.001
MI 1000 (10) 38 (11) 874 (10) 88 (12) 0.11
HF 1380 (15) 45 (15) 1207 (14) 128 (19) 0.010










Death 1087 (23) 43 (20) 863 (22) 181 (29) <0.001
MI 467 (10) 26 (12) 368 (9) 73 (12) 0.07
HF 637 (14) 28 (14) 498 (13) 111 (19) 0.002
Values are expressed as number (percentage). HBW indicates high birth weight; HF,
heart failure; LBW, low birth weight; MBW, medium birth weight; MI, myocardial
infarction.
Figure 1. A, Kaplan–Meier estimates of incident heart failure
(HF) hospitalization by birth weight category in the complete
cohort. B, Kaplan–Meier estimates of incident myocardial infarc-
tion (MI) by birth weight category in the complete cohort. C,
Kaplan–Meier estimates of all-cause mortality by birth weight
category in the complete cohort. The graphs show the unadjusted
Kaplan–Meier estimates of the primary end points in the total
cohort (HF hospitalization, MI, and all-cause mortality).
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birth weights, HBW was also positively associated with an
increased hazard of incident HF (HR, 1.36; 95% CI, 1.09–1.69
[P=0.006]) (Table 4) compared with MBW but not death (HR,
1.14; 95% CI, 0.96–1.35 [P=0.13]) or MI (HR, 1.06; 95% CI,
0.81–1.39 [P=0.67]).
Discussion
In this prospective cohort of biracial community-dwelling
adults in the United States we observed that, after adjusting
for differences in demographics and comorbidities, HBW is
signiﬁcantly associated with a 27% to 36% increased hazard of
incident HF, a trend toward increased mortality, and no
association with MI compared with MBW. Notably, the
association of HBW with incident HF persisted after adjust-
ment for traditional risk factors for HF including age, male sex,
BMI, hypertension, diabetes mellitus, overweight or obesity,
and smoking, suggesting that HBW may be a novel, indepen-
dent risk factor for the development of HF.
An estimated 6.5 million American adults have HF with
projections that its prevalence will increase 46% from 2012
to 2030, resulting in over 8 million adults with HF. It is
estimated that 1 000 000 new cases of HF are diagnosed
annually.16 Data from Olmstead County, MN, indicate that
CHD, hypertension, diabetes mellitus, obesity, and smoking
are responsible for only 52% of incident HF cases in the
population.2 Thus, although greater adherence to the
American Heart Association’s Life’s Simple 7 guidelines
(better proﬁles in smoking, BMI, physical activity, diet,
cholesterol, BP, and glucose) would be expected to lower the
incidence of HF17 associated with traditional risk factors,
even strict adherence would not prevent the development of
HF in the approximately one half of cases unrelated to
traditional risk factors. Thus, the identiﬁcation of new risk
factors is of signiﬁcant public health importance so that new
interventions can be developed to reduce the toll of HF on
patients.
The precise mechanism by which HBW is positively
associated with incident HF and, possibly, mortality is not
known. HBW was not associated with an increased hazard of
MI, suggesting that the mechanism of HF associated with
HBW is not mediated through myocyte loss caused by MI. The
metabolic syndrome represents a cluster of cardiometabolic
risk factors including hypertension, insulin resistance, dyslipi-
demia, and obesity that are associated with an increased risk
of HF.18 Insulin resistance and inﬂammation are thought to be
critical mediators of the syndrome.19,20 However, numerous
studies indicate that LBW, as opposed to HBW, infants are
at increased risk for the development of metabolic syn-
drome.21–23 Similarly, inﬂammatory markers are increased in
adults born at LBW rather than HBW.24–27 Thus, the available
data suggest that although LBW predisposes to metabolic
syndrome and inﬂammation, LBW is not an independent risk
factor for HF. On the other hand, HBW is associated with an
increased risk for obesity and type 2 diabetes mellitus,10–12
Figure 2. A, Kaplan–Meier Estimates of incident heart failure
(HF) hospitalization by birth weight category in the exact birth
weight subgroup. B, Kaplan–Meier estimates of incident
myocardial infarction (MI) by birth weight category in the exact
birth weight subgroup. C, Kaplan–Meier estimates of all-cause
mortality by birth weight category in the exact birth weight
subgroup. The graphs show the unadjusted Kaplan–Meier
estimates of the primary end points in the exact birth weight
cohort (HF hospitalization, MI, and all-cause mortality).
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both of which are risk factors for HF.2 However, after
adjustment for obesity and diabetes mellitus, both of which
are associated with an increased hazard of HF in this study,
HBW remains independently associated with incident HF.
Although the fetal origins of disease hypothesis initially
focused on fetal deprivation in LBW infants,3 its implications
extend beyond the LBW population and include babies
exposed to other forms of metabolic stress during different
critical periods of development, which ultimately result in a
disease state. Mothers with gestational diabetes mellitus are
at increased risk for delivering a neonate at HBW. Gestational
diabetes mellitus results in increased delivery of glucose and
other macronutrients to the fetus, resulting in increased fetal
production of insulin, the dominant fetal growth hormone. The
in utero environment thus promotes the deposition of adipose
tissue and increased insulin secretion early in life, thereby
setting the fetus up for an abnormal body composition and
future disease.3 It remains to be determined how the fetal
milieu imparts a susceptibility to HF in adulthood.
Over 300 000 HBW infants are born in the United States
annually.28 Nonmodiﬁable risk factors for HBW include
parental height, parity, ethnicity, maternal age, infant sex,
and previous delivery of an HBW infant. Maternal weight,
gestational weight gain, and glycemic control are the risk
factors for HBW that are most amenable to intervention
through diet, exercise, and lifestyle modiﬁcation.9 Recent data
suggest that genetic factors also contribute to birth weight
and may drive the development of cardiometabolic diseases in
later life.29
Study Limitations
This analysis has certain limitations. First, echocardiographic
data were not available to characterize HF as a function of left
ventricular structure or function. Second, self-reported birth
weight and birth weight categories were used without
veriﬁcation of their accuracy. However, recalled birth weight
data obtained in the ARIC study followed expected patterns.
Speciﬁcally, recalled exact birth weight was higher in males
than females, and positively correlated with adult height,
weight, and BMI.30 Furthermore, the characteristics and
outcomes of the complete cohort and the exact birth weight
subgroup were concordant, suggesting that estimates of birth
weight categories were as reliable as measures of exact birth
weight. Third, incident HF events not requiring hospitalization
were not captured. However, community surveillance reports
have demonstrated that 74% of outpatients with HF are
hospitalized within 1.7 years.31 Given the extended follow-up
of this cohort, it is likely that most patients diagnosed with HF
in the outpatient setting would have been admitted to the
Table 4. Cox Proportional Hazards Model for Incident HF
Variable
Complete Cohort Exact Birth Weight Subgroup
HR 95% CI P Value HR 95% CI P Value
HBW (vs MBW) 1.27 1.05–1.54 0.014 1.36 1.09–1.69 0.006
LBW (vs MBW) 0.98 0.71–1.35 0.89 1.25 0.84–1.86 0.27
Age (per 1-y increase) 1.09 1.08–1.10 <0.001 1.08 1.07–1.10 <0.001
Female 0.76 0.67–0.88 <0.001 0.80 0.65–0.98 0.033
White 1.07 0.91–1.25 0.43 0.96 (0.75–1.23 0.76
BMI 25 to 29.9 (vs BMI <25) 1.21 1.04–1.41 0.014 1.28 1.02–1.61 0.035
BMI ≥30 (vs BMI <25) 1.94 1.65–2.28 <0.001 1.95 1.53–2.49 <0.001
Current smoking (vs never) 2.87 2.48–3.33 <0.001 3.20 2.57–3.97 <0.001
Former smoking (vs never) 1.34 1.16–1.55 <0.001 1.40 1.14–1.73 0.002
Ethanol intake (per 1-unit increase) 0.99 0.99–1.00 0.024 1.00 0.99–1.00 0.34
Hypertension 1.51 1.31–1.73 <0.001 1.37 1.11–1.69 0.003
Diabetes mellitus 2.36 2.01–2.76 <0.001 2.56 2.04–3.22 <0.001
LVH 1.96 1.43–2.69 <0.001 2.52 1.62–3.92 <0.001
Income $16 000 to 34 999 (vs $0–15 999) 0.85 0.73–0.99 0.038 0.88 0.69–1.11 0.28
Income $35 000+ (vs $0–15 999) 0.65 0.54–0.76 <0.001 0.65 0.51–0.84 <0.001
SBP (per 1-mm Hg increase) 1.008 1.00–1.01 <0.001 1.01 1.00–1.02 0.001
HDL-C (per 1-mmol/L increase) 0.75 0.63–0.89 <0.001 0.80 0.63–1.02 0.07
BMI indicates body mass index; HBW, high birth weight; HDL-C, high-density lipoprotein cholesterol; HF, health failure; LBW, low birth weight; LVH, left ventricular hypertrophy; MBW,
medium birth weight; SBP, systolic blood pressure.
DOI: 10.1161/JAHA.118.011524 Journal of the American Heart Association 7


















 http://ahajournals.org by on June 18, 2019
hospital and captured as an incident HF admission. Fourth, as
with all observational studies, unmeasured and residual
confounding of the relationship between birth weight and
cardiovascular outcomes cannot be completely addressed by
Cox proportional hazards analysis. Finally, without formal
causal mediation analysis we are unable to state precisely
how much of the increased hazard of HF is mediated directly
by HBW. Given the lack of information on maternal health
during the pregnancy, it is possible that HBW is a marker of
maternal weight gain or the development of gestational
diabetes mellitus.
Conclusions
In this analysis of biracial community-dwelling adults in the
United States, HBW was independently associated with
incident HF and may represent a novel risk factor, although
the mechanisms remain to be deﬁned. At this time, the most
effective intervention would appear to be at the level of
maternal nutrition and weight gain. In addition, a history of
HBW should be ascertained in young adults for primordial
prevention of HF and in older adults for primary prevention.
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